Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: The role of charge and architecture

International Journal of Nanomedicine

Volumn 2, Issue 4, 2007, Pages 697-705

  Wang, Jinzhong ^a   Plourde, Nicole M ^c   Iverson, Nicole ^b   Moghe, Prabhas V ^b,c   Uhrich, Kathryn E ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c The State University of New Jersey   (United States)

Author keywords

Amphiphilic macromolecules; Highly oxidized low density lipoproteins; Polymeric micelles; Scavenger receptor inhibition

Indexed keywords

ALKYL GROUP; AMPHOPHILE; ANTILIPEMIC AGENT; BENZOIC ACID DERIVATIVE; BUFFER; CARBOXYLIC ACID DERIVATIVE; MACROGOL; NANOPARTICLE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; HYDRODYNAMICS; HYDROPHILICITY; HYDROPHOBICITY; INHIBITION KINETICS; INTERNALIZATION; LIGHT SCATTERING; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; MACROMOLECULE; MACROPHAGE; MICELLE; MICELLIZATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; SURFACE CHARGE; SYNTHESIS; ZETA POTENTIAL;

ANIMALS; CELL LINE; ELECTROSTATICS; HYDROPHOBICITY; LIPOPROTEINS; MACROMOLECULAR SUBSTANCES; MACROPHAGES; MATERIALS TESTING; MICE; NANOSTRUCTURES; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

EID: 62149083134     PISSN: 11769114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Boullier A, Friedman P, Harkewicz R, et al. 2005. Phosphocholine as a pattern recognition ligand for CD3 6. J Lipid Res, 46:969-76.
2. Brown M, Goldstein J. 1983. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem, 52:223-61.
3. Broz P, Benito S, Saw C, et al. 2005. Cell targeting by a generic receptor-targeted polymer nanocontainer platform. J Control Release, 102:475-88.
4. Camejo G, Olsson U, Hurt-Camejo E, et al. 2002. The extracellular matrix on atherogenesis and diabetes-associated vascular disease. Atherosclerosis Supp, 3-9.
5. Carella M, Volinia S, Gasparini P. 2003. Nanotechnologies and microchips in genetic diseases. J Nephrol, 16:597-602.
6. Chang M, Potter-Perigo S, Wight T, et al. 2001. Oxidized LDL bind to nonproteoglycan components of smooth muscle extracellular matrices. J Lipid Res, 42:824-33.
7. Chnari E, Nikitczuk J, Uhrich K, et al. 2005. Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized low density lipoproteins. Biomacromolecules, 26:3749-58.
8. Chnari E, Nikitczuk J, Wang J, et al. 2006. Engineered Polymeric nanoparticles\ for Receptor-Targeted Blockage of Oxidized Low Density Lipoproteins Uptake and Atherogenesis in macrophages. Biomacromolecules,
9. Djordjevic J, Barch M, Uhrich K. 2005. Polymeric micelles based on amphiphilic scorpion-like macromolecules: novel carriers for water-insoluble drugs. Pharm Res, 22:24-32.
10. Endo M, Koyama S, Matsuda Y, et al. 2005. Thrombogenicity and blood coagulation of a microcatheter prepared from carbon nanotube-nylon-based composite. Nano Lett, 5:101-5.
11. Guaderrama-Diaz M, Solis C, Velasco-Loyden G, et al. 2005. Control of scavenger receptor-mediated endocytosis by novel ligands of different length. Mol Cell Biochem, 271:123-32.
12. He W, Ma Z, Yong T, et al. 2005. Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth. Biomaterials, 26:7606-15.
13. He W, Yong T, Teo W, et al. 2005. Fabrication and endothelialization of collagen-blended biodegradable polymer nanofibers: potential vascular graft for blood vessel tissue engineering. Tissue Eng, 11: 1574-88.
14. Krieger M, Acton S, Ashkenas J, et al. 1993. Molecular Flypaper, Host Defense, and Atherosclerosis: structure, binding properties, and functions of macrophage scavenger receptors. J Biol Chem, 268:4569-72.
15. Ma Z, He W, Yong T, et al. 2005. Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell Orientation. Tissue Eng, 11:1149-58.
16. Malinski T. 2005. Understanding nitric oxide physiology in the heart: a nanomedical approach. Am J Cardiol, 96:13i-24i.
17. Meng J, Kong H, Xu H, et al. 2005, Improving the blood compatibility of polyurethane using carbon nanotubes as fillers and its implications to cardiovascular surgery. J Biomed Mater Res A, 74:208-14.
18. Moghimi S, Szebeni J. 2003. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization, and protein-binding properties. Prog Lipid Res, 42:463-78.
19. Olsson U, Ostergren-Lunden G, Moses J. 2001. Glycosaminoglycan-lipoprotein interaction. Glycoconj J, 18:789-97.
20. Oorni K, Pentikainen M, Annila A, et al. 1997. Oxidation of low density lipoprotein particles decreases their ability to bind to human aortic proteoglycans. J Biol Chem, 272:21303-11.
21. Patel R, Moellering D, Murphy-Ullrich J, et al. 2000. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radical Biol Med, 28:1780-94.
22. Platt N, Gordon S. 2001. Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale. J Clin Invest, 108:649-54.
23. Raynal I, Prigent P, Peyramaure S, et al. 2004. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Investig Radiology, 39:56-63.
24. Steinberg D. 1997. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem, 272:20963-6.
25. Tao L, Uhrich K. 2006. Novel amphiphilic macromolecules and their in vitro characterization as stabilized micellar drug delivery systems. J Colloid Interf Sci, 298:102-10.
26. Thom T, Haase N, Rosamond W, et al. 2006. Heart Disease and Stroke Statistics - 2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 113:e85-e151.
27. Tian L, Yam L, Zhou N, et al. 2004. Amphiphilic scorpion-like macromolecules: design, synthesis, and characterization. Macromolecules, 37:538-42.
28. Traber M, Defendi V, Kayden H. 1981. Receptor activities for low-density lipoprotein and acetylated low-density lipoprotein in a mouse macrophage cell line (IC21) and in human monocyte-derived macrophages. J Exp Med, 154:1852-67.
29. Vonarbourg A, Passirani C, Saulnier P, et al. 2006. Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J Biomed Mater Res, 78A: 620-8.
30. Williams K, Tabas I. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol, 15:551-61.
31. Yoshiizumi K, Nakajima F, Dobashi R, et al. 2004. 2,4-Bis(octadecanoyl amino)benzenesulfonic acid sodium salt as a novel scavenger receptor inhibitor with low molecular weight. Bioorg Med Chem Lett, 14:2791-5.